Action MCAG MOUNTAIN CREST ACQUISITION CORP. V
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Mountain Crest Acquisition Corp. V

Actions

MCAG

US62404B1070

Marché Fermé - Nasdaq
Autres places de cotation
 19:18:21 02/05/2024 		Varia. 5j. Varia. 1 janv.
10,6 USD +1,24 % Graphique intraday de Mountain Crest Acquisition Corp. V +1,24 % -0,66 %
2023 Mountain Crest Acquisition Corp. V présente ses résultats pour le troisième trimestre et les neuf mois clos le 30 septembre 2023 CI
2023 Mountain Crest Acquisition Corp. V présente ses résultats pour le deuxième trimestre et le semestre clos le 30 juin 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
CUBEBIO Co., Ltd. entered into terms relating to a potential business combination with Mountain Crest Acquisition Corp. V
Mountain Crest Acquisition : New Financial Obligation - Form 8-K
Mountain Crest Acquisition Corp. V announced that it has received $0.3 million in funding
Mountain Crest Acquisition Corp. V Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Mountain Crest Acquisition Corp. V announced that it has received $0.4 million in funding
Mountain Crest Acquisition Corp. V Primary Exchange Listing will Change to Nasdaq Capital Market from Nasdaq Global Market
Mountain Crest Acquisition Corp. V Announces Listing Transfer to the Nasdaq Capital Market
Mountain Crest Acquisition Corp. V Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Mountain Crest Acquisition : Termination of Material Agreement - Form 8-K
MOUNTAIN CREST ACQUISITION CORP. V : Termination of a Material Definitive Agreement (form 8-K)
AUM Biosciences Pte. Ltd. cancelled the acquisition of Mountain Crest Acquisition Corp. V from a group of shareholders in a reverse merger transaction.
AUM Biosciences Doses First Patient in Phase 2 Clinical Trial of AUM001 in Metastatic Colorectal Cancer
Mountain Crest Acquisition : Failure to Satisfy Listing Rule - Form 8-K
MOUNTAIN CREST ACQUISITION CORP. V : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
Mountain Crest Acquisition Corp. V Reports Earnings Results for the First Quarter Ended March 31, 2023
MOUNTAIN CREST ACQUISITION CORP. V : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AUM Biosciences to Participate in Inaugural EF Hutton Global Conference
MOUNTAIN CREST ACQUISITION CORP. V : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
MOUNTAIN CREST ACQUISITION CORP. V : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
MOUNTAIN CREST ACQUISITION CORP. V MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action MCAG
  4. Actualités Mountain Crest Acquisition Corp. V
  5. Autres langues